Literature DB >> 29858582

Antigen-specific regulatory T-cell responses against aeroantigens and their role in allergy.

Petra Bacher1, Alexander Scheffold2.   

Abstract

The mucosal immune system of the respiratory tract is specialized to continuously monitor the external environment and to protect against invading pathogens, while maintaining tolerance to innocuous inhaled particles. Allergies result from a loss of tolerance against harmless antigens characterized by formation of allergen-specific Th2 cells and IgE. Tolerance is often described as a balance between harmful Th2 cells and various types of protective "regulatory" T cells. However, the identity of the protective T cells in healthy vs. allergic individuals or following successful allergen-specific therapy is controversially discussed. Recent technological progress enabling the identification of antigen-specific effector and regulatory T cells has significantly contributed to our understanding of tolerance. Here we discuss the experimental evidence for the various tolerance mechanisms described. We try to integrate the partially contradictory data into a new model proposing different mechanism of tolerance depending on the quality and quantity of the antigens as well as the way of antigen exposure. Understanding the basis of tolerance is essential for the rational design of novel and more efficient immunotherapies.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29858582     DOI: 10.1038/s41385-018-0038-z

Source DB:  PubMed          Journal:  Mucosal Immunol        ISSN: 1933-0219            Impact factor:   7.313


  4 in total

1.  Epithelial cell-derived CD83 restores immune tolerance in the airway mucosa by inducing regulatory T-cell differentiation.

Authors:  Li-Hua Mo; Xiang-Qian Luo; Gui Yang; Jiang-Qi Liu; Li-Teng Yang; Zhi-Qiang Liu; Shuai Wang; Da-Bo Liu; Zhi-Gang Liu; Ping-Chang Yang
Journal:  Immunology       Date:  2021-02-28       Impact factor: 7.215

2.  Functionally specialized human CD4+ T-cell subsets express physicochemically distinct TCRs.

Authors:  Sofya A Kasatskaya; Kristin Ladell; David A Price; Dmitriy M Chudakov; Evgeniy S Egorov; Kelly L Miners; Alexey N Davydov; Maria Metsger; Dmitry B Staroverov; Elena K Matveyshina; Irina A Shagina; Ilgar Z Mamedov; Mark Izraelson; Pavel V Shelyakin; Olga V Britanova
Journal:  Elife       Date:  2020-12-08       Impact factor: 8.140

Review 3.  Innovative Systems to Deliver Allergen Powder for Epicutaneous Immunotherapy.

Authors:  Yensheng Wang; Yifei Kong; Mei X Wu
Journal:  Front Immunol       Date:  2021-03-26       Impact factor: 7.561

Review 4.  Nucleic Acid-Based Approaches for Tumor Therapy.

Authors:  Simone Hager; Frederic Julien Fittler; Ernst Wagner; Matthias Bros
Journal:  Cells       Date:  2020-09-09       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.